136 related articles for article (PubMed ID: 24474572)
1. Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution.
Kim K; Chie EK; Park HJ; Kim DG; Jung HW; Park SH; Kim IH
Clin Transl Oncol; 2014 Sep; 16(9):829-33. PubMed ID: 24474572
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
3. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
[TBL] [Abstract][Full Text] [Related]
4. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri: improved outcome with radiotherapy.
Perkins GH; Schomer DF; Fuller GN; Allen PK; Maor MH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1137-46. PubMed ID: 12829152
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
7. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Mattox AK; Lark AL; Adamson DC
Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
[TBL] [Abstract][Full Text] [Related]
8. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
9. [Gliomatosis cerebri: clinico-pathological and neuroimaging characteristics and the results of treatment with radiotherapy].
Mena IX; Olivares DA; del Brutto OH; Leone-Stay G
Rev Neurol; 2000 Jul 16-31; 31(2):101-6. PubMed ID: 10951662
[TBL] [Abstract][Full Text] [Related]
10. Gliomatosis cerebri: a review of 22 cases.
Vates GE; Chang S; Lamborn KR; Prados M; Berger MS
Neurosurgery; 2003 Aug; 53(2):261-71; discussion 271. PubMed ID: 12925240
[TBL] [Abstract][Full Text] [Related]
11. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Levin N; Gomori JM; Siegal T
Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
[TBL] [Abstract][Full Text] [Related]
14. [A case of gliomatosis cerebri: remarkable improvement after radiation therapy].
Hata N; Katsuta T; Inoue T; Uehara S; Takeshita M
No Shinkei Geka; 2001 May; 29(5):409-14. PubMed ID: 11449711
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.
Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Zaboronok A; Takano S; Matsumura A
Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis.
Hales RK; Shokek O; Burger PC; Paynter NP; Chaichana KL; Quiñones-Hinojosa A; Jallo GI; Cohen KJ; Song DY; Carson BS; Wharam MD
J Neurooncol; 2010 Aug; 99(1):65-71. PubMed ID: 20043190
[TBL] [Abstract][Full Text] [Related]
17. Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients.
Georgakis MK; Tsivgoulis G; Pourtsidis A; Petridou ET
J Child Neurol; 2019 Jun; 34(7):394-401. PubMed ID: 30887873
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy approach in gliomatosis cerebri--case reports and literature review.
Horst E; Micke O; Romppainen ML; Pyhtinen J; Paulus W; Schäfer U; Rübe C; Willich N
Acta Oncol; 2000; 39(6):747-51. PubMed ID: 11130015
[TBL] [Abstract][Full Text] [Related]
19. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]